CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,367 shares at $19.67 ($26,889)
- 4 Open-market sale President & CEO sold 11,885 shares at $19.67 ($233,778)
- 4 Open-market sale SVP, COO & CFO sold 8,245 shares at an average $19.67 ($162,199)
- 4 Open-market sale Director sold 15,009 shares at $25.00 ($375,225)
- 4 Open-market sale Director sold 8,000 shares at $24.58 ($196,640)
- 4 Open-market sale Chief R&D Officer sold 4,558 shares at $22.51 ($102,601)
- 4 Open-market sale SVP & General Counsel sold 1,529 shares at $22.51 ($34,418)
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,367 shares at $22.51 ($30,771)
- 4 Open-market sale President & CEO sold 8,968 shares at $22.51 ($201,870)
- 4 Open-market sale SVP, COO & CFO sold 7,727 shares at an average $22.54 ($174,155)
- 4 Open-market sale Director sold 8,000 shares at an average $18.38 ($147,010)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 8,000 shares at an average $16.79 ($134,316)
- 4 Open-market sale Chief R&D Officer sold 4,774 shares at $22.35 ($106,699)
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,394 shares at $22.35 ($31,156)
- 4 Open-market sale President & CEO sold 8,448 shares at $22.35 ($188,813)
- 4 Open-market sale SVP, COO & CFO sold 5,938 shares at $22.35 ($132,714)
- 4 Open-market sale Director sold 8,000 shares at an average $23.50 ($188,000)
- 4 Open-market sale SVP & Chief Accounting Officer sold 37,500 shares at $22.78 ($854,250)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
Page 12 of 49 · 970 filings